Fairman Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Fairman Group's RGEN Position: Q1 2025 in Review
Fairman Group sold out of Repligen (RGEN) in Q1 2025, closing a stake of 4 shares — an estimated $576 sold.
Fairman Group first reported a position in RGEN in Q4 2023 and held it in 5 quarters. The position peaked at $1.47K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Fairman Group reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Fairman Group sold 4 Repligen shares in Q1 2025, an estimated $576.
- Fairman Group first reported a position in Repligen in Q4 2023 and held it in 5 quarters.
- Fairman Group's Repligen position peaked at $1.47K in Q1 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.